Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management
- PMID: 36212092
- PMCID: PMC9535265
- DOI: 10.1016/j.gore.2022.101068
Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management
Abstract
Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon.
Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months.
Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.
Keywords: Germ cell tumor; Ovarian germ cell tumor; Pure ovarian dysgerminoma.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Bailey J.o., Church D.N. Management of germ cell tumours of the ovary. Rev. Gynaecol. Pract. 2005;5(4):201–206.
-
- Barakat R.R., et al. Principles and Practice of Gynecologic Oncology. third ed., Wolters Kluwer Health; 2013. Ovarian germ cell tumors; pp. 851–860.
-
- Boussios S., et al. Malignant ovarian germ cell tumors in postmenopausal patients: the royal marsden experience and literature review. Anticancer Res. 2015;35(12):6713–6722. - PubMed
-
- Clement P.B., et al. Elsevier; Edinburgh: 2020. Atlas of Gynecologic Surgical Pathology. pp. 360–361.
-
- de Wit R., et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2001;19(6):1629–1640. doi: 10.1200/JCO.2001.19.6.1629. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources